Searchable abstracts of presentations at key conferences in endocrinology

ea0049gp89 | Diabetes & complications 2 | ECE2017

Clinical assessment of trabecular bone microstructure in type 2 diabetes mellitus with Trabecular Bone Score (TBS)

Perez Maria Dolores Aviles , Martin Antonia Garcia , Rodriguez Cristina Novo , Serrano Rafael Nieto , Vela Elena Torres , Torres Manuel Munoz

Introduction: Type 2 diabetes mellitus (T2DM) is a risk factor for osteoporotic fractures although bone mineral density is increased. As such, there is a need for improved approaches to estimate fracture risk in such individuals. The Trabecular Bone Score (TBS) is a new technique to determine the trabecular bone microarchitecture.Objective: Our aim was to evaluate evaluate the usefulness of TBS in T2DM patients.Methods: We compared...

ea0056p509 | Diabetes therapy | ECE2018

Addition of sodium-glucose co-transporter type 2 inhibitors to diabetic patients type 2 in treatment with glucagon-like peptide-1 agonists: clinical results

Laguna Ma del Carmen Serrano , Ponce Maria Hayon , Martinez David Blanquez , Perez Maria Dolores Aviles , Vela Elena Torres

Background: The complex involvement of multiple metabolic defects in the pathogenesis of type 2 diabetes mellitus (T2DM) makes difficult the treatment in monotherapy, therefore, the use of different antidiabetic drugs with different and complementary mechanisms of action could result in better glycemic control with favorable metabolic changes.Objective: To determine the effectiveness and safety of the addition of a sodium-glucose co-transporter type 2 in...

ea0056p907 | Endocrine Disruptors | ECE2018

Cross hormone therapy in transgender individuals: changes in lipid profile and other cardiovascular risk factor

Laguna Ma del Carmen Serrano , Ponce Maria Hayon , Martinez David Blanquez , Perez Maria Dolores Aviles , Vela Elena Torres

Background: Cross-sex hormone therapy (CHT) is known to lead to alterations in cardiovascular risk factor(CVRF).Objective: To assess changes in lipid profile and other CVRF in transsexual subjects receiving CHT.Materials and methods: Retrospective longitudinal study. We evaluated individuals with gender identity disorder following CHT, assisted in the Gender Identity Unit from 2015 to 2017. Primary endpoint was lipid profile change...